Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).
Year: 2023
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aaron Scott Mansfield, Austin Goodrich, Nathan R. Foster, Panos Savvides, Liza C Villaruz, Patrick M. Forde, Kanwal Pratap Singh Raghav, Paul Bernard Romesser, Diane Feldman, Liang Cao, Mary M. Salvatore, Anja C. Roden, Steven Francis Powell, Ardaman Shergill, Pamela N. Munster, Gary K. Schwartz, Travis Edward Grotz
Institutions: Mayo Clinic, Mayo Clinic in Arizona, University of Pittsburgh Medical Center, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, National Cancer Institute, Columbia University Irving Medical Center, Sanford Health, University of Chicago Medical Center, University of California, San Francisco
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4379338738